In the last Quality Conversation, I discussed the clinical governance issues that arose from the Djerriwarrh Health Services clinical governance failure case in Victoria in 2015. In this Conversation I ask: If that’s what clinical governance failure looks like, what are high performing boards and executives doing differently?
